Skip links

Inquiries

Send a message.

We’re here to answer any question you may have.

    NEURSANTYS

    Recent News and Press Releases

    14

    MARCH

    2023

    Bioelectronics Pioneer Neursantys Expands Executive Team, Advisory Board, and Investor Base.
    7

    MARCH

    2023

    NEURVESTA bioelectronic wearable selected as finalist for Product Design of the Year award.
    16

    FEB

    2023

    Neursantys and other semi-finalists in Canadian Space Agency Deep Space Healthcare Challenge share their solutions, inspirations, and experiences with Impact Canada.
    10

    FEB

    2023

    Chief Science Officer Ryan Peters and CEO John Ralston to showcase Neursantys innovations at the Hotchkiss Brain Institute NEUROVATION event in Calgary.
    2

    FEB

    2023

    Neursantys and University of Calgary research into improving balance and gait mobility in older adults could help those with neurological impairments like stroke and Parkinson’s disease.
    8

    DEC

    2022

    Neursantys CEO John Ralston to join “Mobility for an Aging Population” panel at Washington D.C. Longevity Innovation Summit
    30

    NOV

    2022

    Dual-use remote care applications of NEURVESTA to be showcased at Canadian Space Agency 2022 Health Beyond Summit
    24

    NOV

    2022

    Neursantys and University of Calgary Pilot Wearable Device to Treat Age-Related Balance Decline
    4

    NOV

    2022

    Neursantys selected to present to investors at the 2022 Silicon Valley Leaders Forum HealthTech Showcase
    20

    OCT

    2022

    Neursantys announces know-how agreement with Mayo Clinic
    18

    OCT

    2022

    Neursantys CEO John Ralston to present at BIOSENSORS FOR MEDICAL WEARABLES, 24-25 October 2022, Boston, USA Title: “Wearable device integration of neurophysiological
    diagnostic and therapeutic capabilities”
    20

    July

    2022

    Neursantys Establishes Advisory Board, Announces New Members.
    11

    July

    2022

    University of Calgary researchers highlight potential application of NEURVESTA device to address increased motion sickness that often accompanies aging.
    30

    June

    2022

    Neursantys Wins $10K Business Plan Competition at 2022 What’s Next Longevity Venture Summit
    17

    June

    2022

    Neursantys to showcase the NEURVESTA wearable at mHUB’s 5 Year Anniversary Product Showcase in Chicago on June 23rd
    8

    June

    2022

    Congratulations to Neursantys for winning the 19th Annual What’s Next Longevity Venture Summit Business Plan Competition.
    25

    MAY

    2022

    Canadian Space Agency selects Neursantys as semi-finalist in Deep Space Healthcare Challenge to develop innovative healthcare technologies for remote communities and long duration space missions
    24

    MAY

    2022

    Neursantys selected as Finalist in 19th Annual What’s Next Longevity Venture Summit Business Plan Competition.
    10

    MAR

    2022

    Neursantys to present at MedCity INVEST, the premier national healthcare investing conference, March 28-30, 2022, Chicago
    28

    Feb

    2022

    Neursantys CEO John Ralston to present at 12th Annual Neurotalk Global Congress, June 15-17, 2022, Singapore

    Title: “Integrating Diagnostic and Therapeutic Capabilities into Non-Invasive Wearable Solutions for the Management of Complex Neurological Conditions”

    07

    Dec

    2021

    PROTXX Phybrata Sensor Technology Selected by Neursantys for Wearable Neuroprosthetic Device
    30

    Nov

    2021

    Neursantys Selected for mHUB Premier MedTech Accelerator Cohort in Chicago
    10

    Nov

    2021

    mHUB Announces Portfolio Teams of Premier MedTech Accelerator Cohort

    Startups to Participate in the Chicago-Based Program Are Developing Novel Solutions for Patient Monitoring, Drug Delivery and Therapeutic Devices

    🍪 This website uses cookies to improve your web experience.